Eneda Toska

13PUBLICATIONS
149CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsGlobal and planetary environmental engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 11, 2025
The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer.

Srushti Kittane, Erik Ladewig, Taibo Li

|Nov 21, 2025
Androgen Receptor Drives Polyamine Synthesis, Creating a Vulnerability for Prostate Cancer.

Rajendra Kumar, Sheila Jonnatan, David E Sanin

|Jun 04, 2025
Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers.

Yanyan Cai, Peihua Zhao, Fan Wu

|Jun 20, 2024
Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents.

Paola Roa, Valentina Foglizzo, Guilherme Harada

|Dec 08, 2023
ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma.

Kasturee Jagirdar, Marie E Portuallo, Meihan Wei

|Mar 22, 2023
Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer.

Anna Bianchi, Iago De Castro Silva, Nilesh U Deshpande

Pageof 3

Frequent Collaborators

8 joint publications

Maurizio Scaltriti

4 joint publications

Emiliano Cocco

4 joint publications

Christina S Leslie

4 joint publications

José Baselga